Exploring Liver Disease and Long COVID

This chapter examines the rising public health challenges of metabolic-associated steatotic liver disease (MASH) and non-alcoholic steatohepatitis (NASH) in Canada, alongside a cohort study on the effectiveness of COVID vaccines in preventing long COVID. It details the methodologies, demographics, and findings related to the impact of vaccination on long COVID risk, stressing the importance of continued vaccination efforts amidst growing public hesitancy.